
exteRNA creates small-molecule therapeutics that modulate RNA processing and protein function. It designs precision molecules using synthetic biology and nonstandard amino acids, guided by machine learning and medicinal chemistry. Core technologies include synthetic biology, nonstandard amino acids, and ML-guided design. The company targets RNA processing pathways and protein therapeutics across biotech and pharma collaborations. Its approach aims to scale through partnerships with pharmaceutical developers.

exteRNA creates small-molecule therapeutics that modulate RNA processing and protein function. It designs precision molecules using synthetic biology and nonstandard amino acids, guided by machine learning and medicinal chemistry. Core technologies include synthetic biology, nonstandard amino acids, and ML-guided design. The company targets RNA processing pathways and protein therapeutics across biotech and pharma collaborations. Its approach aims to scale through partnerships with pharmaceutical developers.